Skip to main content
Equibles

Redmile Group, LLC

Position in IVVD — Invivyd, Inc.

CIK 1425738 Larkspur, CA
Back to IVVD Full portfolio

Position in IVVD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,265,245
-$1,178,011 QoQ
Shares Held
2,597,759
-1.9% QoQ
Ownership
0.881%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#21
of 124 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IVVD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Redmile Group, LLC holds $1,454,356,867 across 35 Biotechnology names. IVVD ranks #34 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SRRK
Scholar Rock Holding Corp
 4,311,092 $237,110,060
2 KRYS
Krystal Biotech, Inc.
 632,005 $234,897,298
3 STOK
Stoke Therapeutics, Inc.
 3,945,920 $129,110,502
4 IMNM
Immunome Inc.
 4,911,590 $104,076,592
5 NRIX
Nurix Therapeutics, Inc.
 4,073,787 $98,830,072
6 ABSI
Absci Corp
 6,739,675 $78,112,833
7 ANNX
Annexon, Inc.
 11,869,877 $67,776,997
8 RGNX
REGENXBIO Inc.
 4,368,804 $52,338,271

All Filings in IVVD

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,265,245 2,597,759
2026-03-31 $3,443,256 2,648,659
2025-12-31 $6,622,462 2,681,159
2025-09-30 $2,513,852 2,285,320
2025-06-30 $1,634,003 2,285,320
2025-03-31 $1,382,618 2,285,320
2024-12-31 $1,334,428 3,012,254
2024-09-30 $3,127,028 3,065,714
2024-06-30 $3,372,285 3,065,714
2024-03-31 $6,396,819 1,440,725
2023-12-31 $5,676,456 1,440,725
2023-09-30 $2,449,232 1,440,725
2023-06-30 $1,512,761 1,440,725
2023-03-31 $1,728,870 1,440,725
2022-12-31 $2,161,087 1,440,725
2022-09-30 $6,012,604 1,920,960
2022-06-30 $6,300,748 1,920,960
2022-03-31 $8,759,577 1,920,960
2021-12-31 $13,946,169 1,920,960
2021-09-30 $137,151,590 3,246,960